Short-term (1-year) survival in patients with idiopathic pulmonary arterial hypertension (PPH) and the Eisenmenger syndrome (congenital heart disease-associated pulmonary hypertension [CHD-PH]) as a function of the circulating (plasma) levels of von Willebrand factor (vWF:Ag). For any given level of vWF:Ag, the probability of survival is considerably higher for patients with CHD-PH. Reproduced from Ref. 6, with permission.
Additional keywords: von Willebrand Factor,vWF,eisenmenger,iPAH